高等学校化学学报 ›› 2016, Vol. 37 ›› Issue (6): 1100.doi: 10.7503/cjcu20160042
收稿日期:
2016-01-18
出版日期:
2016-06-10
发布日期:
2016-05-18
作者简介:
联系人简介: 王宝雷, 男, 博士, 副研究员, 主要从事有机化学和农药化学研究. E-mail:基金资助:
ZHANG Yan, WANG Baolei*(), ZHAN Yizhou, ZHANG Liyuan, LI Yonghong, LI Zhengming
Received:
2016-01-18
Online:
2016-06-10
Published:
2016-05-18
Contact:
WANG Baolei
E-mail:nkwbl@nankai.edu.cn
Supported by:
摘要:
根据药物分子设计的活性基团组合原理, 通过在1,2,4-三唑环的5位引入吡啶基, 同时在4位芳基亚甲氨基的苯环上引入氟或三氟甲基, 设计合成了一系列含氟、 吡啶和哌嗪基团的1,2,4-三唑Mannich碱和双Mannich碱类化合物. 通过核磁共振氢谱(1H NMR)、 碳谱(13C NMR)和元素分析确证了目标化合物的结构. 生物活性测试结果表明, 部分化合物对油菜具有一定的除草活性; 化合物2a, 2d和2f(50 mg/L)对苹果轮纹病菌表现出较好的抑制活性, 与对照药三唑酮活性相当; 化合物2a, 2b, 2d和2i(180 mg/L)对酮醇酸还原异构酶(KARI酶)表现出了显著的离体抑制活性(抑制率51.7%~88.7%).
中图分类号:
TrendMD:
张燕, 王宝雷, 詹益周, 张丽媛, 李永红, 李正名. 新型含取代哌嗪的5-(吡啶-3-基)-1,2,4-三唑Mannich碱和双Mannich碱的合成及生物活性. 高等学校化学学报, 2016, 37(6): 1100.
ZHANG Yan, WANG Baolei, ZHAN Yizhou, ZHANG Liyuan, LI Yonghong, LI Zhengming. Synthesis and Biological Activities of Novel 5-(Pyridine-3-yl)-1,2,4-triazole Mannich Bases and Bis-Mannich Bases Containing Piperazine Moiety†. Chem. J. Chinese Universities, 2016, 37(6): 1100.
Compd. | Apperance | m.p./℃ | Yield(%) | Elemental analysis(%, calcd.) | ||
---|---|---|---|---|---|---|
C | H | N | ||||
1a | White solid | 246—247 | 90 | 55.97(56.18) | 3.52(3.37) | 23.15(23.40) |
1b | White solid | 261—262 | 94 | 51.60(51.57) | 2.75(2.89) | 19.98(20.05) |
2a | White solid | 118—119 | 83 | 59.85(59.82) | 4.89(4.83) | 18.60(18.78) |
2b | White solid | 137—138 | 86 | 56.47(56.12) | 4.26(4.35) | 17.62(17.78) |
2c | White solid | 134—135 | 91 | 63.67(63.41) | 4.78(5.11) | 20.91(20.70) |
2d | White solid | 190—191 | 81 | 59.26(59.62) | 5.20(5.20) | 24.62(25.03) |
2e | White solid | 147—148 | 74 | 60.73(60.74) | 4.89(4.89) | 23.39(23.61) |
2f | White solid | 125—127 | 99 | 56.84(56.69) | 4.61(4.41) | 17.23(17.14) |
2g | White solid | 136—138 | 89 | 53.38(53.47) | 3.92(3.99) | 16.23(16.17) |
2h | White solid | 130—131 | 83 | 59.51(59.64) | 4.80(4.62) | 18.49(18.73) |
2i | White solid | 128—130 | 99 | 55.51(55.65) | 4.80(4.48) | 23.73(23.36) |
2j | White solid | 125—126 | 66 | 56.18(56.41) | 4.70(4.73) | 22.56(22.77) |
2k | White solid | 151—152 | 90 | 56.95(57.24) | 4.45(4.42) | 21.22(21.36) |
3a | White solid | 235—236 | 58 | 57.60(57.61) | 4.21(4.27) | 24.05(23.71) |
3b | White solid | 224—226 | 99 | 53.33(53.46) | 3.81(3.74) | 20.90(20.78) |
Table 1 Apperance, melting points, yields and elemental analysis data of compounds 1a, 1b, 2a—2k, 3a and 3b
Compd. | Apperance | m.p./℃ | Yield(%) | Elemental analysis(%, calcd.) | ||
---|---|---|---|---|---|---|
C | H | N | ||||
1a | White solid | 246—247 | 90 | 55.97(56.18) | 3.52(3.37) | 23.15(23.40) |
1b | White solid | 261—262 | 94 | 51.60(51.57) | 2.75(2.89) | 19.98(20.05) |
2a | White solid | 118—119 | 83 | 59.85(59.82) | 4.89(4.83) | 18.60(18.78) |
2b | White solid | 137—138 | 86 | 56.47(56.12) | 4.26(4.35) | 17.62(17.78) |
2c | White solid | 134—135 | 91 | 63.67(63.41) | 4.78(5.11) | 20.91(20.70) |
2d | White solid | 190—191 | 81 | 59.26(59.62) | 5.20(5.20) | 24.62(25.03) |
2e | White solid | 147—148 | 74 | 60.73(60.74) | 4.89(4.89) | 23.39(23.61) |
2f | White solid | 125—127 | 99 | 56.84(56.69) | 4.61(4.41) | 17.23(17.14) |
2g | White solid | 136—138 | 89 | 53.38(53.47) | 3.92(3.99) | 16.23(16.17) |
2h | White solid | 130—131 | 83 | 59.51(59.64) | 4.80(4.62) | 18.49(18.73) |
2i | White solid | 128—130 | 99 | 55.51(55.65) | 4.80(4.48) | 23.73(23.36) |
2j | White solid | 125—126 | 66 | 56.18(56.41) | 4.70(4.73) | 22.56(22.77) |
2k | White solid | 151—152 | 90 | 56.95(57.24) | 4.45(4.42) | 21.22(21.36) |
3a | White solid | 235—236 | 58 | 57.60(57.61) | 4.21(4.27) | 24.05(23.71) |
3b | White solid | 224—226 | 99 | 53.33(53.46) | 3.81(3.74) | 20.90(20.78) |
Compd. | 1H NMR(400 MHz), δ | 13C NMR(101 MHz), δ |
---|---|---|
1aa | 14.42(s, 1H, SH), 9.81(s, 1H, N=CH), 9.04(s, 1H, Pyridine-H), 8.74(d, J=4.5 Hz, 1H, Pyridine-H ), 8.28(d, J=7.8 Hz, 1H, Pyridine-H), 8.01—7.95(m, 2H, Ph—H), 7.63—7.58(m, 1H, Pyridine-H), 7.42(t, J=8.5 Hz, 2H, Ph—H) | 165.7, 163.6(C=S), 162.5, 151.3(CH=N), 148.7, 146.8(Triazole-C), 135.9, 131.40(d, J=9.0 Hz, F—Ph—C), 128.6, 123.8 , 122.0, 116.5 |
1ba | 14.47(s, 1H, SH), 10.09(s, 1H, N=CH), 9.05(s, 1H, Pyridine-H), 8.75(d, J=4.5 Hz, 1H, Pyridine-H), 8.27(d, J=7.9 Hz, 1H, Pyridine-H), 8.12(d, J=8.0 Hz, 2H, Ph—H), 7.94(d, J=8.0 Hz, 2H, Ph—H), 7.60(dd, J=7.9, 4.5 Hz, 1H, Pyridine-H) | 163.9(C=S), 162.6(s), 151.0(CH=N), 148.5, 147.0(Triazole-C), 136.7, 135.9, 132.3(d, J=33.3 Hz, CF3—Ph—C), 129.5, 126.3, 124.1, 123.9(q, J=273.7 Hz, CF3), 122.2 |
2ab | 10.23(s, 1H, N=CH), 9.21(s, 1H, Pyridine-H), 8.74(s, 1H, Pyridine-H), 8.26(s, 1H, Pyridine-H), 7.89—7.85(m, 2H, Ph—H), 7.46—7.42(s, 1H, Pyridine-H), 7.27—7.16(m, 6H, Ph—H), 5.26(s, 2H, CH2), 3.45(s, 2H, CH2), 2.98—2.91(m, 4H, Piperazine-CH2), 2.65—2.25(m, 4H, Piperazine-CH2) | 165.5, 164.0(C=S), 162.3, 151.4(CH=N), 149.5, 146.0(Triazole-C), 136.6, 135.9, 132.8, 131.2(d, J=9.0 Hz, F—Ph—C), 130.4, 128.5, 128.4, 123.3, 122.0, 116.1, 69.6, 62.3, 53.0, 50.5 |
2bb | 10.25(s, 1H, N=CH), 9.22(s, 1H, Pyridine-H), 8.74(d, J=4.7 Hz, 1H, Pyridine-H), 8.27(d, J=8.0 Hz, 1H, Pyridine-H), 7.90—7.86(m, 2H, Ph—H), 7.44(dd, J=8.0, 4.7 Hz, 1H, Pyridine-H), 7.38—7.32(m, 2H, Ph—H), 7.20—7.16(m, 3H, Ph—H), 5.28(s, 2H, CH2), 3.56(s, 2H, CH2), 2.98—2.90(m, 4H, Piperazine-CH2), 2.61—2.48(m, 4H, Piperazine-CH2) | 165.5, 164.1(C=S), 162.3, 151.4(CH=N), 149.5, 146.0(Triazole-C), 135.9, 134.8, 134.5, 133.1, 131.4, 131.2(d, J=9.0 Hz, F—Ph—C), 129.2, 128.5, 126.9, 123.3, 122.1, 116.5, 69.7, 58.7, 53.1, 50.6 |
2cb | 10.24(s, 1H, N=CH), 9.21(s, 1H, Pyridine-H), 8.74(d, J=3.8 Hz, 1H, Pyridine-H), 8.27(d, J=8.0 Hz, 1H, Pyridine-H), 7.91—7.85(m, 2H, Ph—H), 7.44(dd, J=8.0, 3.8 Hz, 1H, Pyridine-H), 7.28—7.23(m, 2H, Ph—H), 7.18(t, J=8.5 Hz, 2H, Ph—H), 6.91(d, J=8.1 Hz, 2H, Ph—H), 6.86(t, J=7.2 Hz, 1H, Ph—H), 5.34(s, 2H, CH2), 3.24—3.20(m, 4H, Piperazine-CH2), 3.10—3.04(m, 4H, Piperazine-CH2) | 165.6, 165.1(C=S), 162.4, 151.5(CH=N), 151.3, 149.5, 146.1(Triazole-C), 136.0, 131.2(d, J=9.0 Hz, F—Ph—C), 129.2, 128.5, 123.4, 122.0, 120.0, 116.5, 116.4, 69.6, 50.6, 49.6 |
2db | 10.24(s, 1H, N=CH), 9.20(s, 1H, Pyridine-H), 8.73(d, J=4.5 Hz, 1H, Pyridine-H), 8.25(d, J=7.9 Hz, 1H, Pyridine-H), 7.91—7.84(m, 2H, Ph—H), 7.43(dd, J=7.9, 4.5 Hz, 1H, Pyridine-H), 7.18(t, J=8.4 Hz, 2H, Ph—H), 6.23(s, 1H, Pyrimidin-H), 5.34(s, 2H, CH2), 3.95—3.87(m, 4H, Piperazine-CH2), 2.97—2.90(m, 4H, Piperazine-CH2), 2.25(s, 6H, CH3) | 167.1(C=S), 165.5, 164.1, 162.3, 161.6, 151.4(CH=N), 149.5, 146.0(Triazole-C), 135.9, 131.2(d, J=9.0 Hz, F—Ph—C), 128.5, 123.3, 122.0, 116.5, 108.9, 69.9, 50.7, 43.6, 24.1 |
2eb | 10.23(s, 1H, N=CH), 9.20(s, 1H, Pyridine-H), 8.73(s, 1H, Pyridine-H), 8.26(d, J=6.3 Hz, 1H, Pyridine-H), 8.16(s, 1H, Pyridine-H), 7.87(d, J=7.1 Hz, 2H, Ph—H), 7.50—7.37(m, 2H, Pyridine-H), 7.19(d, J=7.1 Hz, 2H, Ph—H), 6.68—6.50(m, 2H, Pyridine-H), 5.34(s, 2H, CH2), 3.68—3.52(s, 4H, Piperazine-CH2), 3.10—2.93(s, 4H, Piperazine-CH2) | 165.5, 164.0(C=S), 162.4, 159.3, 151.5(CH=N), 149.5, 148.0, 146.1(Triazole-C), 137.5, 136.0, 131.2(d, J=9.0 Hz, F—Ph—C), 128.5, 123.4, 122.0, 116.5, 113.3, 107.1, 69.7, 50.4, 45.2 |
2fb | 10.58(s, 1H, N=CH), 9.19(d, J=1.6 Hz, 1H, Pyridine-H), 8.75(d, J=4.8 Hz, 1H, Pyridine-H), 8.24(dd, J=8.0, 1.6 Hz, 1H, Pyridine-H), 7.97(d, J=8.1 Hz, 2H, Ph—H), 7.75(d, J=8.1 Hz, 2H, Ph—H), 7.45(dd, J=8.0, 4.8 Hz, 1H, Pyridine-H), 7.26—7.18(m, 4H, Ph—H), 5.28(s, 2H, CH2), 3.45(s, 2H, CH2), 2.96—2.88(m, 4H, Piperazine-CH2), 2.53—2.43(m, 4H, Piperazine-CH2) | 164.0(C=S), 160.5, 151.6(CH=N), 149.6, 146.2(Triazole-C), 136.6, 136.1, 135.7, 133.9(d, J=33.0 Hz, CF3—Ph—C), 132.8, 130.4, 129.1, 128.4, 126.1, 123.6(q, J=272.7 Hz, CF3), 123.4, 121.9, 69.6, 62.3, 53.0, 50.5 |
2gb | 10.58(s, 1H, N=CH), 9.19(d, J=1.6 Hz, 1H, Pyridine-H), 8.76(d, J=5.0 Hz, 1H, Pyridine-H), 8.26(dd, J=8.0 Hz, 1.6 Hz, 1H, Pyridine-H), 7.97(d, J=8.1 Hz, 2H, Ph—H), 7.75(d, J=8.1 Hz, 2H, Ph—H), 7.46(dd, J=8.0, 5.0 Hz, 1H, Pyridine-H), 7.35(m, 2H, Ph—H), 7.17(dd, J=8.2, 1.8 Hz, 1H, Ph—H), 5.26(s, 2H, CH2), 3.56(s, 2H, CH2), 2.97—2.92(m, 4H, Piperazine-CH2), 2.85—2.30(m, 4H, Piperazine-CH2) | 164.0(C=S), 160.5, 151.6(CH=N), 149.6, 146.2(Triazole-C), 136.1, 135.7, 135.1, 134.9, 134.5, 134.0(d, J=32.3 Hz, CF3—Ph—C), 133.1, 131.4, 129.1, 126.9, 126.1, 123.6(q, J=275.7 Hz, CF3), 123.4, 121.9, 69.6, 58.7, 53.1, 50.6 |
2hb | 10.59(s, 1H, N=CH), 9.20(d, J=1.4 Hz, 1H, Pyridine-H), 8.76(d, J=4.4 Hz, 1H, Pyridine-H), 8.25(d, J=8.3, 1.4 Hz, 1H, Pyridine-H), 7.97(d, J=8.0 Hz, 2H, Ph—H), 7.75(d, J=8.0 Hz, 2H, Ph—H), 7.46(dd, J=8.3, 4.4 Hz, 1H, Pyridine-H) , 7.25(d, J=9.5 Hz, 2H, Ph—H), 6.92(d, J=7.9 Hz, 2H, Ph—H), 6.86(t, J=7.1 Hz, 1H, Ph—H), 5.34(s, 2H, CH2), 3.26—3.18(m, 4H, Piperazine-CH2), 3.11—2.98(m, 4H, Piperazine-CH2) | 164.1(C=S), 160.6, 151.6(CH=N), 151.3, 149.6, 146.3(Triazole-C), 136.1, 135.7, 134.0(d, J=32.3 Hz, CF3—Ph—C), 129.2, 129.1, 126.1, 123.6(q, J=273.7 Hz, CF3), 123.4, 121.9, 120.1, 116.5, 69.6, 50.6, 49.5 |
2ib | 10.57(s, 1H, N=CH), 9.19(s, 1H, Pyridine-H), 8.75(d, J=4.0 Hz, 1H, Pyridine-H), 8.24(d, J=7.8 Hz, 1H, Pyridine-H), 8.13(d, J=4.8 Hz, 1H, Pyrimidin-H), 7.96(d, J=7.8 Hz, 2H, Ph—H), 7.74(d, J=7.9 Hz, 2H, Ph—H), 7.47—7.42(m, 1H, Pyridine-H), 6.34(d, J=4.8 Hz, 1H, Pyrimidin-H), 5.34(s, 2H, CH2), 3.92—3.86(m, 4H, Piperazine-CH2), 2.99—2.93(m, 4H, Piperazine-CH2), 2.30(s, 3H, CH3) | 167.7(C=S), 164.0, 161.5, 160.6, 157.2, 151.5(CH=N), 149.6, 146.2(Triazole-C), 136.2, 135.9, 133.9(d, J=33.3 Hz, CF3—Ph—C) 129.1, 126.1, 123.6(q, J=274.7 Hz, CF3), 123.4, 121.9, 109.5, 69.8, 50.6, 43.6, 24.3 |
2jb | 10.57(s, 1H, N=CH), 9.18(d, J=1.5 Hz, 1H, Pyridine-H), 8.74(dd, J=4.9, 1.5 Hz, 1H, Pyridine-H), 8.23(d, J=8.0 Hz, 1H, Pyridine-H), 7.96(d, J=8.1 Hz, 2H, Ph—H), 7.74(d, J=8.1 Hz, 2H, Ph—H), 7.44(dd, J=8.0, 4.9 Hz, 1H, Pyridine-H), 6.23(s, 1H, Pyrimidin-H), 5.34(s, 2H, CH2), 3.92—3.88(m, 4H, Piperazine-CH2), 2.97—2.93(m, 4H, Piperazine-CH2), 2.26(s, 6H, CH3) | 167.1(C=S), 164.0, 161.6, 160.6, 151.5(CH=N), 149.6, 146.2(Triazole-C), 136.1, 135.7, 133.9(q, J=32.3 Hz, CF3—Ph—C), 129.1, 126.1, 123.6(q, J=273.7 Hz, CF3), 123.4, 121.9, 109.0, 69.9, 50.7, 43.5, 24.1 |
2kb | 10.58(s, 1H, N=CH), 9.19(s, 1H, Pyridine-H), 8.75(d, J=4.4 Hz, 1H, Pyridine-H), 8.24(d, J=7.5 Hz, 1H, Pyridine-H), 8.16(d, J=3.4 Hz, 1H, Pyridine-H), 7.97(d, J=7.8 Hz, 2H, Ph—H), 7.74(d, J=7.8 Hz, 2H, Ph—H), 7.45(dd, J=10.5, 5.9 Hz, 2H, Pyridine-H), 6.61(dd, J=13.4, 7.4 Hz, 2H, Pyridine-H), 5.34(s, 2H, CH2), 3.62—3.53(m, 4H, Piperazine-CH2), 3.05—2.96(m, 4H, Piperazine-CH2) | 164.1(C=S), 160.6, 159.3, 151.6(CH=N), 149.6, 148.0, 146.3(Triazole-C), 133.9(d, J=33.3 Hz, CF3—Ph—C), 137.5, 136.1, 135.7, 129.1, 126.1, 123.6(q, J=273.7 Hz, CF3), 123.4, 121.9, 113.4, 107.1, 69.7, 50.4, 45.23 |
3ab | 10.23(s, 2H, N=CH), 9.20(s, 2H, Pyridine-H), 8.74(d, J=3.6 Hz, 2H, Pyridine-H), 8.25(d, J=7.2 Hz, 2H, Pyridine-H), 7.87(t, J=8.2 Hz, 4H, Ph—H), 7.46—7.41(m, 2H, Pyridine-H), 7.18(t, J=8.2 Hz, 4H, Ph—H), 5.24(s, 4H, CH2), 2.96(s, 8H, Piperazine-CH2) | 165.5, 164.0(C=S), 160.6, 151.4(CH=N), 149.5, 146.0(Triazole-C), 136.1, 131.2(d, J=9.0 Hz, F—Ph—C), 128.5, 123.3, 122.0, 116.5, 69.9, 50.6 |
3bb | 10.57(s, 2H, N=CH), 9.18(s, 2H, Pyridine-H), 8.75(s, 2H, Pyridine-H), 8.24(s, 2H, Pyridine-H), 7.96(d, J=7.2 Hz, 4H, Ph—H), 7.74(d, J=7.2 Hz, 4H, Ph—H), 7.45(s, 2H, Pyridine-H), 5.24(s, 4H, CH2), 2.96(s, 8H, Piperazine-CH2) | 163.9(C=S), 160.5, 151.6(CH=N), 149.6, 146.3(Triazole-C), 136.1, 135.6, 133.9(d, J=33.3 Hz, CF3—Ph—C), 129.1, 126.1, 123.6(q, J=273.7 Hz, CF3), 123.4, 121.8, 69.6, 50.5 |
Table 2 1H NMR and 13C NMR data of compounds 1a, 1b, 2a—2k, 3a and 3b
Compd. | 1H NMR(400 MHz), δ | 13C NMR(101 MHz), δ |
---|---|---|
1aa | 14.42(s, 1H, SH), 9.81(s, 1H, N=CH), 9.04(s, 1H, Pyridine-H), 8.74(d, J=4.5 Hz, 1H, Pyridine-H ), 8.28(d, J=7.8 Hz, 1H, Pyridine-H), 8.01—7.95(m, 2H, Ph—H), 7.63—7.58(m, 1H, Pyridine-H), 7.42(t, J=8.5 Hz, 2H, Ph—H) | 165.7, 163.6(C=S), 162.5, 151.3(CH=N), 148.7, 146.8(Triazole-C), 135.9, 131.40(d, J=9.0 Hz, F—Ph—C), 128.6, 123.8 , 122.0, 116.5 |
1ba | 14.47(s, 1H, SH), 10.09(s, 1H, N=CH), 9.05(s, 1H, Pyridine-H), 8.75(d, J=4.5 Hz, 1H, Pyridine-H), 8.27(d, J=7.9 Hz, 1H, Pyridine-H), 8.12(d, J=8.0 Hz, 2H, Ph—H), 7.94(d, J=8.0 Hz, 2H, Ph—H), 7.60(dd, J=7.9, 4.5 Hz, 1H, Pyridine-H) | 163.9(C=S), 162.6(s), 151.0(CH=N), 148.5, 147.0(Triazole-C), 136.7, 135.9, 132.3(d, J=33.3 Hz, CF3—Ph—C), 129.5, 126.3, 124.1, 123.9(q, J=273.7 Hz, CF3), 122.2 |
2ab | 10.23(s, 1H, N=CH), 9.21(s, 1H, Pyridine-H), 8.74(s, 1H, Pyridine-H), 8.26(s, 1H, Pyridine-H), 7.89—7.85(m, 2H, Ph—H), 7.46—7.42(s, 1H, Pyridine-H), 7.27—7.16(m, 6H, Ph—H), 5.26(s, 2H, CH2), 3.45(s, 2H, CH2), 2.98—2.91(m, 4H, Piperazine-CH2), 2.65—2.25(m, 4H, Piperazine-CH2) | 165.5, 164.0(C=S), 162.3, 151.4(CH=N), 149.5, 146.0(Triazole-C), 136.6, 135.9, 132.8, 131.2(d, J=9.0 Hz, F—Ph—C), 130.4, 128.5, 128.4, 123.3, 122.0, 116.1, 69.6, 62.3, 53.0, 50.5 |
2bb | 10.25(s, 1H, N=CH), 9.22(s, 1H, Pyridine-H), 8.74(d, J=4.7 Hz, 1H, Pyridine-H), 8.27(d, J=8.0 Hz, 1H, Pyridine-H), 7.90—7.86(m, 2H, Ph—H), 7.44(dd, J=8.0, 4.7 Hz, 1H, Pyridine-H), 7.38—7.32(m, 2H, Ph—H), 7.20—7.16(m, 3H, Ph—H), 5.28(s, 2H, CH2), 3.56(s, 2H, CH2), 2.98—2.90(m, 4H, Piperazine-CH2), 2.61—2.48(m, 4H, Piperazine-CH2) | 165.5, 164.1(C=S), 162.3, 151.4(CH=N), 149.5, 146.0(Triazole-C), 135.9, 134.8, 134.5, 133.1, 131.4, 131.2(d, J=9.0 Hz, F—Ph—C), 129.2, 128.5, 126.9, 123.3, 122.1, 116.5, 69.7, 58.7, 53.1, 50.6 |
2cb | 10.24(s, 1H, N=CH), 9.21(s, 1H, Pyridine-H), 8.74(d, J=3.8 Hz, 1H, Pyridine-H), 8.27(d, J=8.0 Hz, 1H, Pyridine-H), 7.91—7.85(m, 2H, Ph—H), 7.44(dd, J=8.0, 3.8 Hz, 1H, Pyridine-H), 7.28—7.23(m, 2H, Ph—H), 7.18(t, J=8.5 Hz, 2H, Ph—H), 6.91(d, J=8.1 Hz, 2H, Ph—H), 6.86(t, J=7.2 Hz, 1H, Ph—H), 5.34(s, 2H, CH2), 3.24—3.20(m, 4H, Piperazine-CH2), 3.10—3.04(m, 4H, Piperazine-CH2) | 165.6, 165.1(C=S), 162.4, 151.5(CH=N), 151.3, 149.5, 146.1(Triazole-C), 136.0, 131.2(d, J=9.0 Hz, F—Ph—C), 129.2, 128.5, 123.4, 122.0, 120.0, 116.5, 116.4, 69.6, 50.6, 49.6 |
2db | 10.24(s, 1H, N=CH), 9.20(s, 1H, Pyridine-H), 8.73(d, J=4.5 Hz, 1H, Pyridine-H), 8.25(d, J=7.9 Hz, 1H, Pyridine-H), 7.91—7.84(m, 2H, Ph—H), 7.43(dd, J=7.9, 4.5 Hz, 1H, Pyridine-H), 7.18(t, J=8.4 Hz, 2H, Ph—H), 6.23(s, 1H, Pyrimidin-H), 5.34(s, 2H, CH2), 3.95—3.87(m, 4H, Piperazine-CH2), 2.97—2.90(m, 4H, Piperazine-CH2), 2.25(s, 6H, CH3) | 167.1(C=S), 165.5, 164.1, 162.3, 161.6, 151.4(CH=N), 149.5, 146.0(Triazole-C), 135.9, 131.2(d, J=9.0 Hz, F—Ph—C), 128.5, 123.3, 122.0, 116.5, 108.9, 69.9, 50.7, 43.6, 24.1 |
2eb | 10.23(s, 1H, N=CH), 9.20(s, 1H, Pyridine-H), 8.73(s, 1H, Pyridine-H), 8.26(d, J=6.3 Hz, 1H, Pyridine-H), 8.16(s, 1H, Pyridine-H), 7.87(d, J=7.1 Hz, 2H, Ph—H), 7.50—7.37(m, 2H, Pyridine-H), 7.19(d, J=7.1 Hz, 2H, Ph—H), 6.68—6.50(m, 2H, Pyridine-H), 5.34(s, 2H, CH2), 3.68—3.52(s, 4H, Piperazine-CH2), 3.10—2.93(s, 4H, Piperazine-CH2) | 165.5, 164.0(C=S), 162.4, 159.3, 151.5(CH=N), 149.5, 148.0, 146.1(Triazole-C), 137.5, 136.0, 131.2(d, J=9.0 Hz, F—Ph—C), 128.5, 123.4, 122.0, 116.5, 113.3, 107.1, 69.7, 50.4, 45.2 |
2fb | 10.58(s, 1H, N=CH), 9.19(d, J=1.6 Hz, 1H, Pyridine-H), 8.75(d, J=4.8 Hz, 1H, Pyridine-H), 8.24(dd, J=8.0, 1.6 Hz, 1H, Pyridine-H), 7.97(d, J=8.1 Hz, 2H, Ph—H), 7.75(d, J=8.1 Hz, 2H, Ph—H), 7.45(dd, J=8.0, 4.8 Hz, 1H, Pyridine-H), 7.26—7.18(m, 4H, Ph—H), 5.28(s, 2H, CH2), 3.45(s, 2H, CH2), 2.96—2.88(m, 4H, Piperazine-CH2), 2.53—2.43(m, 4H, Piperazine-CH2) | 164.0(C=S), 160.5, 151.6(CH=N), 149.6, 146.2(Triazole-C), 136.6, 136.1, 135.7, 133.9(d, J=33.0 Hz, CF3—Ph—C), 132.8, 130.4, 129.1, 128.4, 126.1, 123.6(q, J=272.7 Hz, CF3), 123.4, 121.9, 69.6, 62.3, 53.0, 50.5 |
2gb | 10.58(s, 1H, N=CH), 9.19(d, J=1.6 Hz, 1H, Pyridine-H), 8.76(d, J=5.0 Hz, 1H, Pyridine-H), 8.26(dd, J=8.0 Hz, 1.6 Hz, 1H, Pyridine-H), 7.97(d, J=8.1 Hz, 2H, Ph—H), 7.75(d, J=8.1 Hz, 2H, Ph—H), 7.46(dd, J=8.0, 5.0 Hz, 1H, Pyridine-H), 7.35(m, 2H, Ph—H), 7.17(dd, J=8.2, 1.8 Hz, 1H, Ph—H), 5.26(s, 2H, CH2), 3.56(s, 2H, CH2), 2.97—2.92(m, 4H, Piperazine-CH2), 2.85—2.30(m, 4H, Piperazine-CH2) | 164.0(C=S), 160.5, 151.6(CH=N), 149.6, 146.2(Triazole-C), 136.1, 135.7, 135.1, 134.9, 134.5, 134.0(d, J=32.3 Hz, CF3—Ph—C), 133.1, 131.4, 129.1, 126.9, 126.1, 123.6(q, J=275.7 Hz, CF3), 123.4, 121.9, 69.6, 58.7, 53.1, 50.6 |
2hb | 10.59(s, 1H, N=CH), 9.20(d, J=1.4 Hz, 1H, Pyridine-H), 8.76(d, J=4.4 Hz, 1H, Pyridine-H), 8.25(d, J=8.3, 1.4 Hz, 1H, Pyridine-H), 7.97(d, J=8.0 Hz, 2H, Ph—H), 7.75(d, J=8.0 Hz, 2H, Ph—H), 7.46(dd, J=8.3, 4.4 Hz, 1H, Pyridine-H) , 7.25(d, J=9.5 Hz, 2H, Ph—H), 6.92(d, J=7.9 Hz, 2H, Ph—H), 6.86(t, J=7.1 Hz, 1H, Ph—H), 5.34(s, 2H, CH2), 3.26—3.18(m, 4H, Piperazine-CH2), 3.11—2.98(m, 4H, Piperazine-CH2) | 164.1(C=S), 160.6, 151.6(CH=N), 151.3, 149.6, 146.3(Triazole-C), 136.1, 135.7, 134.0(d, J=32.3 Hz, CF3—Ph—C), 129.2, 129.1, 126.1, 123.6(q, J=273.7 Hz, CF3), 123.4, 121.9, 120.1, 116.5, 69.6, 50.6, 49.5 |
2ib | 10.57(s, 1H, N=CH), 9.19(s, 1H, Pyridine-H), 8.75(d, J=4.0 Hz, 1H, Pyridine-H), 8.24(d, J=7.8 Hz, 1H, Pyridine-H), 8.13(d, J=4.8 Hz, 1H, Pyrimidin-H), 7.96(d, J=7.8 Hz, 2H, Ph—H), 7.74(d, J=7.9 Hz, 2H, Ph—H), 7.47—7.42(m, 1H, Pyridine-H), 6.34(d, J=4.8 Hz, 1H, Pyrimidin-H), 5.34(s, 2H, CH2), 3.92—3.86(m, 4H, Piperazine-CH2), 2.99—2.93(m, 4H, Piperazine-CH2), 2.30(s, 3H, CH3) | 167.7(C=S), 164.0, 161.5, 160.6, 157.2, 151.5(CH=N), 149.6, 146.2(Triazole-C), 136.2, 135.9, 133.9(d, J=33.3 Hz, CF3—Ph—C) 129.1, 126.1, 123.6(q, J=274.7 Hz, CF3), 123.4, 121.9, 109.5, 69.8, 50.6, 43.6, 24.3 |
2jb | 10.57(s, 1H, N=CH), 9.18(d, J=1.5 Hz, 1H, Pyridine-H), 8.74(dd, J=4.9, 1.5 Hz, 1H, Pyridine-H), 8.23(d, J=8.0 Hz, 1H, Pyridine-H), 7.96(d, J=8.1 Hz, 2H, Ph—H), 7.74(d, J=8.1 Hz, 2H, Ph—H), 7.44(dd, J=8.0, 4.9 Hz, 1H, Pyridine-H), 6.23(s, 1H, Pyrimidin-H), 5.34(s, 2H, CH2), 3.92—3.88(m, 4H, Piperazine-CH2), 2.97—2.93(m, 4H, Piperazine-CH2), 2.26(s, 6H, CH3) | 167.1(C=S), 164.0, 161.6, 160.6, 151.5(CH=N), 149.6, 146.2(Triazole-C), 136.1, 135.7, 133.9(q, J=32.3 Hz, CF3—Ph—C), 129.1, 126.1, 123.6(q, J=273.7 Hz, CF3), 123.4, 121.9, 109.0, 69.9, 50.7, 43.5, 24.1 |
2kb | 10.58(s, 1H, N=CH), 9.19(s, 1H, Pyridine-H), 8.75(d, J=4.4 Hz, 1H, Pyridine-H), 8.24(d, J=7.5 Hz, 1H, Pyridine-H), 8.16(d, J=3.4 Hz, 1H, Pyridine-H), 7.97(d, J=7.8 Hz, 2H, Ph—H), 7.74(d, J=7.8 Hz, 2H, Ph—H), 7.45(dd, J=10.5, 5.9 Hz, 2H, Pyridine-H), 6.61(dd, J=13.4, 7.4 Hz, 2H, Pyridine-H), 5.34(s, 2H, CH2), 3.62—3.53(m, 4H, Piperazine-CH2), 3.05—2.96(m, 4H, Piperazine-CH2) | 164.1(C=S), 160.6, 159.3, 151.6(CH=N), 149.6, 148.0, 146.3(Triazole-C), 133.9(d, J=33.3 Hz, CF3—Ph—C), 137.5, 136.1, 135.7, 129.1, 126.1, 123.6(q, J=273.7 Hz, CF3), 123.4, 121.9, 113.4, 107.1, 69.7, 50.4, 45.23 |
3ab | 10.23(s, 2H, N=CH), 9.20(s, 2H, Pyridine-H), 8.74(d, J=3.6 Hz, 2H, Pyridine-H), 8.25(d, J=7.2 Hz, 2H, Pyridine-H), 7.87(t, J=8.2 Hz, 4H, Ph—H), 7.46—7.41(m, 2H, Pyridine-H), 7.18(t, J=8.2 Hz, 4H, Ph—H), 5.24(s, 4H, CH2), 2.96(s, 8H, Piperazine-CH2) | 165.5, 164.0(C=S), 160.6, 151.4(CH=N), 149.5, 146.0(Triazole-C), 136.1, 131.2(d, J=9.0 Hz, F—Ph—C), 128.5, 123.3, 122.0, 116.5, 69.9, 50.6 |
3bb | 10.57(s, 2H, N=CH), 9.18(s, 2H, Pyridine-H), 8.75(s, 2H, Pyridine-H), 8.24(s, 2H, Pyridine-H), 7.96(d, J=7.2 Hz, 4H, Ph—H), 7.74(d, J=7.2 Hz, 4H, Ph—H), 7.45(s, 2H, Pyridine-H), 5.24(s, 4H, CH2), 2.96(s, 8H, Piperazine-CH2) | 163.9(C=S), 160.5, 151.6(CH=N), 149.6, 146.3(Triazole-C), 136.1, 135.6, 133.9(d, J=33.3 Hz, CF3—Ph—C), 129.1, 126.1, 123.6(q, J=273.7 Hz, CF3), 123.4, 121.8, 69.6, 50.5 |
Compd. | Herbicidal activity(%) | Compd. | Herbicidal activity(%) | Compd. | Herbicidal activity(%) | |||
---|---|---|---|---|---|---|---|---|
Brassica campestris | Echinochloa crusgalli | Brassica campestris | Echinochloa crusgalli | Brassica campestris | Echinochloa crusgalli | |||
2a | 16.7 | 5.0 | 2f | 0 | 20.0 | 2k | 0 | 9.0 |
2b | 42.2 | 5.0 | 2g | 28.1 | 13.0 | 3a | 10.3 | 0 |
2c | 0 | 0 | 2h | 0 | 5.0 | 3b | 0 | 0 |
2d | 3.4 | 0 | 2i | 0 | 10.0 | Chlorsulfuron | 80.4 | 22.9 |
2e | 0 | 10.0 | 2j | 29.3 | 13.0 | CPD | 76.8 | 7.0 |
Table 3 Herbicidal activity data of the title compounds at 100 mg/L concentration
Compd. | Herbicidal activity(%) | Compd. | Herbicidal activity(%) | Compd. | Herbicidal activity(%) | |||
---|---|---|---|---|---|---|---|---|
Brassica campestris | Echinochloa crusgalli | Brassica campestris | Echinochloa crusgalli | Brassica campestris | Echinochloa crusgalli | |||
2a | 16.7 | 5.0 | 2f | 0 | 20.0 | 2k | 0 | 9.0 |
2b | 42.2 | 5.0 | 2g | 28.1 | 13.0 | 3a | 10.3 | 0 |
2c | 0 | 0 | 2h | 0 | 5.0 | 3b | 0 | 0 |
2d | 3.4 | 0 | 2i | 0 | 10.0 | Chlorsulfuron | 80.4 | 22.9 |
2e | 0 | 10.0 | 2j | 29.3 | 13.0 | CPD | 76.8 | 7.0 |
Compd. | Aatifungal activity(%) | ||||||
---|---|---|---|---|---|---|---|
A. citrullinaSmith | C. arachidicola | P. piricola | R. cerealis | A. solani | G. zeaePetch | ||
2a | 12.5 | 10.3 | 53.1 | 18.5 | 17.6 | 18.2 | |
2b | 5.0 | 0.0 | 37.5 | 29.6 | 17.6 | 18.2 | |
2c | 10.0 | 13.8 | 28.1 | 30.9 | 23.5 | 9.1 | |
2d | 10.0 | 24.1 | 50.0 | 43.2 | 17.6 | 27.3 | |
2e | 2.5 | 13.8 | 20.3 | 24.7 | 23.5 | 9.1 | |
2f | 10.0 | 10.3 | 51.6 | 45.7 | 29.4 | 18.2 | |
2g | 10.0 | 10.3 | 25.0 | 35.8 | 11.8 | 9.1 | |
2h | 15.0 | 6.9 | 28.1 | 39.5 | 17.6 | 4.5 | |
2i | 10.0 | 6.9 | 25.0 | 32.1 | 23.5 | 27.3 | |
2j | 10.0 | 10.3 | 35.9 | 43.2 | 23.5 | 27.3 | |
2k | 7.5 | 3.4 | 3.1 | 34.6 | 17.6 | 9.1 | |
3a | 12.5 | 17.2 | 12.5 | 24.7 | 29.4 | 27.3 | |
3b | 0.0 | 10.3 | 7.8 | 29.6 | 11.8 | 9.1 | |
Triadimefon | 50.0 | 34.5 | 53.1 | 93.8 | 52.9 | 45.5 |
Table 4 In vitro antifungal activity of the title compounds at the concentration of 50 mg/L
Compd. | Aatifungal activity(%) | ||||||
---|---|---|---|---|---|---|---|
A. citrullinaSmith | C. arachidicola | P. piricola | R. cerealis | A. solani | G. zeaePetch | ||
2a | 12.5 | 10.3 | 53.1 | 18.5 | 17.6 | 18.2 | |
2b | 5.0 | 0.0 | 37.5 | 29.6 | 17.6 | 18.2 | |
2c | 10.0 | 13.8 | 28.1 | 30.9 | 23.5 | 9.1 | |
2d | 10.0 | 24.1 | 50.0 | 43.2 | 17.6 | 27.3 | |
2e | 2.5 | 13.8 | 20.3 | 24.7 | 23.5 | 9.1 | |
2f | 10.0 | 10.3 | 51.6 | 45.7 | 29.4 | 18.2 | |
2g | 10.0 | 10.3 | 25.0 | 35.8 | 11.8 | 9.1 | |
2h | 15.0 | 6.9 | 28.1 | 39.5 | 17.6 | 4.5 | |
2i | 10.0 | 6.9 | 25.0 | 32.1 | 23.5 | 27.3 | |
2j | 10.0 | 10.3 | 35.9 | 43.2 | 23.5 | 27.3 | |
2k | 7.5 | 3.4 | 3.1 | 34.6 | 17.6 | 9.1 | |
3a | 12.5 | 17.2 | 12.5 | 24.7 | 29.4 | 27.3 | |
3b | 0.0 | 10.3 | 7.8 | 29.6 | 11.8 | 9.1 | |
Triadimefon | 50.0 | 34.5 | 53.1 | 93.8 | 52.9 | 45.5 |
Compd. | Inhibition(%) | Compd. | Inhibition(%) | Compd. | Inhibition(%) | Compd. | Inhibition(%) | Compd. | Inhibition(%) |
---|---|---|---|---|---|---|---|---|---|
2a | 63.6 | 2d | 51.7 | 2g | 21.5 | 2j | 27.0 | 3b | 29.9 |
2b | 53.7 | 2e | 10.4 | 2h | 0 | 2k | 15.6 | ||
2c | 29.7 | 2f | 37.8 | 2i | 88.7 | 3a | 28.9 | CPD | 100 |
Table 5 In vitro inhibitory activity(inhibition) of the title compounds against rice KARI at the concentration of 180 mg/L
Compd. | Inhibition(%) | Compd. | Inhibition(%) | Compd. | Inhibition(%) | Compd. | Inhibition(%) | Compd. | Inhibition(%) |
---|---|---|---|---|---|---|---|---|---|
2a | 63.6 | 2d | 51.7 | 2g | 21.5 | 2j | 27.0 | 3b | 29.9 |
2b | 53.7 | 2e | 10.4 | 2h | 0 | 2k | 15.6 | ||
2c | 29.7 | 2f | 37.8 | 2i | 88.7 | 3a | 28.9 | CPD | 100 |
[1] | Zhu Q. S., Progress in Chemistry, 2000, 12(4), 410—414 |
(朱清时. 化学进展, 2000, 12(4), 410—414) | |
[2] | Thornton J., Pure Appl. Chem., 2001, 73(8), 1231—1236 |
[3] | Srivastava K. P., Res. J. Chem. Environ., 2001, 5(2), 77—79 |
[4] | Liu J. C., He H. W., Feng X. M., Chin. J. Pestic., 2005, 44(1), 1—3 |
(刘建超, 贺红武, 冯新民. 农药, 2005, 44(1), 1—3) | |
[5] | Skerritt J. H., Davies L. P., Johnston G. A. R., Eur. J. Pharmacol., 1982, 82(3), 195—197 |
[6] | Wang S. B., Jin P., Li F. N., Quan Z. S., Eur. J. Med. Chem., 2014, 84, 574—583 |
[7] | Pravin K. S., J. Agric. Food. Chem., 2012, 60, 5813—5818 |
[8] | Li Q. Z., Song B. A., Cai X. J., Zheng G. Y., Guo Q. Q., Chin. J. Org. Chem., 2010, 30(4), 569—575 |
(李黔柱, 宋宝安, 蔡学健, 郑国玉, 郭晴晴. 有机化学, 2010, 30(4), 569—575) | |
[9] | Zheng G. Y., Guo Q. Q., Wang Q. H., Wen Q., Zhou L., Zhang G. Y., Chin. J. Synth. Chem., 2015, 23(8),729—732 |
(郑国玉, 郭晴晴, 王清河, 文青, 周莉, 张国义. 合成化学, 2015, 23(8),729—732) | |
[10] | Juan J. M., Maria J. M., Emma P., Angel M., J. Agric. Food. Chem., 2008, 56(19), 8793—8800 |
[11] | Zhai X., Zhao Y. F., Liu Y. J., Zhang Y., Xun F. Q., Liu J., Gong P., Chem. Pharm. Bull., 2008, 56(7), 941—945 |
[12] | Wang M. H., Zhu R. Z., Fan Z. J., Fu Y. F., Feng L., Yao J. H., Alain M., Xia Y., Qu F. Q., Peng L., Bioorg. Med. Chem. Lett., 2011, 21(1), 354—357 |
[13] | Li H., Tatlock J., Linton A., Gonzalez J., Jewell T., Patel L., Ludlum S., Drowns M., Rahavendran S. V., Skor H., Hunter R., Shi S. T., Herlihy K. J., Parge H., Hickey M., Yu X., Chau F., Nonomiya J., Lewis C., J. Med. Chem., 2009, 52(5), 1255—1258 |
[14] | Brandvang M., Charnock C., Gundersen L. L., Bioorg. Med. Chem. Lett., 2009, 19(12), 3297—3299 |
[15] | Xu Y., Xue S. J., Chem. Res. Chinese Universities, 2009, 25(6), 846—850 |
[16] | Lahm G. P., Selby T. P., Freudenberger J. H., Stevenson T. M., Myers B. J., Seburyamo G., Smith B. K., Flexner L., Clark C. E., Cordova D., Bioorg. Med. Chem. Lett., 2005, 15(22), 4898—4906 |
[17] | Glenmark G. L., Preparation of Prasugrel and Its Hydrochloride Salt and Crystal Forms, WO 2010070677, 2010-06-24 |
[18] | Hamid M. H. S. A., Allen C. L., Lamb G. W., Maxwell A. C., Maytum H. C., Watson A. J. A., Williams J. M. J., J. Am. Chem. Soc., 2009, 131(5), 1766—1774 |
[19] | Ochi T., Sakamoto M., Minamida A., Suzuki K., Ueda T., Une T., Toda H., Matsumoto K., Terauchi Y., Bioorg. Med. Chem. Lett., 2005, 15(4), 1055—1059 |
[20] | Tosoh C., O-(5,6,7,8-Tetrahydro-2-naphthyl)-N-(6-methoxy-2-pyridyl)-N-methyl-thiocarbamate of Minimum Inorganic Salt Content and Their Preparation, JP 2006298832, 2006-11-02 |
[21] | Wyeth L., Improved Process for Preparation of Coupled Products from 4-Amino-3-cyanoquinolines Using Stabilized Intermediates, WO 2010048477, 2010-04-29 |
[22] | Suzuki H., Utsunomiya I., Shudo K., Fukuhara N., Iwaki T., Yasukata T., Eur. J. Med. Chem., 2013, 69, 262—277 |
[23] | Nagesh H. N., Suresh A., Sairam S. D. S. S., Sriram D., Yogeeswari P., Sekhar K. V. G. C., Eur. J. Med. Chem., 2014, 84, 605—613 |
[24] | Bourke J. B., Nelsen T. R., Eichler D., J. Agric. Food Chem., 1977, 25(1), 36—39 |
[25] | Xiong Q. Z., Lin X. F., Liu J. H., Bi L., Bao X. P., Chin. J. Org. Chem., 2012, 32(7), 1255—1260 |
(熊启中, 林选福, 刘军虎, 毕亮, 鲍小平. 有机化学, 2012, 32(7), 1255—1260) | |
[26] | Wang B. L., Shi Y. X., Ma Y., Liu X. H., Li Y. H., Song H. B., Li B. J., Li Z. M., J. Agric. Food. Chem., 2010, 58(23), 5515—5522 |
[27] | Zhang L. Y., Wang B. L., Zhan Y. Z., Zhang Y., Zhang X., Li Z. M., Chin. Chem. Let., 2016, 27, 163—167 |
[28] | Wang B. L., Zhang L. Y., Zhan Y. Z., Zhang Y., Zhang X., Wang L. Z., Li Z. M., J. Fluorine Chem., 2016, 184, 36—44 |
[29] | Wang B. L., Liu X.H., Zhang X. L., Zhang J. F., Song H. B., Li Z. M., Chem. Biol. Drug Des., 2011, 78(1), 42—49 |
[30] | Wang B. L., Shi Y. X., Zhan Y. Z., Zhang L. Y., Zhang Y., Wang L. Z., Zhang X., Li Y. H., Li Z. M., Li B. J., Chin. J. Chem., 2015, 33, 1124—1134 |
[31] | Manishkumar B. P., Nishith R. M., Jignesh P. R., Shobhana K. M., Org. Biomol. Chem., 2012, 10, 1785—1794 |
[32] | Chekmeneva E., Hunter C. A., Packer M. J., Turega S. M., J. Am. Chem. Soc., 2008, 130(52), 17718—17725 |
[33] | Liu Z. M., Yang G. F., Qin X. H., J. Chem. Technol. Biotechnol., 2001, 76(11), 1154—1158 |
[34] | Lee Y. T., Ta H. T., Duggleby R. G., Plant Sci., 2005, 168(4), 1035—1040 |
[35] | Hill C. M., Duggleby R. G., Protein. Expres. Purif., 1999, 15(1), 57—61 |
[36] | Wu J. D., Liu X. Y., Cheng X. C., Cao Y., Wang D. F., Li Z., Xu W. F., Pannecouque C., Witvrouw M., Clercq E. D., Molecules, 2007, 12(8), 2003—2016 |
[1] | 赵梦阳, 黄紫洋. HA/CuO/SrCO3梯度复合涂层的制备及体外生物活性[J]. 高等学校化学学报, 2022, 43(2): 20210644. |
[2] | 李伦, 张静妍, 罗静, 刘仁, 朱乙. UV/Vis-LED激发的香豆素吡啶鎓盐光引发剂的合成及性能[J]. 高等学校化学学报, 2022, 43(10): 20220178. |
[3] | 常慧, 姚双全, 韩文佳, 康榭娜, 张力, 李新平, 张召. 三联吡啶化合物的溶剂致荧光变色及丁醇异构体鉴别[J]. 高等学校化学学报, 2021, 42(3): 902. |
[4] | 魏思敏,王英辉,唐志书,苏瑞,胡锦航,郭惠,李琛,蒋金涛,宋忠兴. 紫外光辐射山茱萸水提液制备纳米银及生物活性[J]. 高等学校化学学报, 2020, 41(6): 1391. |
[5] | 刘亚冰,李明阳,田戈,阿拉腾沙嘎,裴桐鹤,聂婧思. 基于2-氨基吡啶的两个簇基超分子化合物的合成、 结构及催化性能[J]. 高等学校化学学报, 2020, 41(5): 995. |
[6] | 尹少云, 张露尹, 王政, 潘梅. “眼镜”状碘化亚铜配合物的调光和双光子发光性质[J]. 高等学校化学学报, 2020, 41(4): 646. |
[7] | 林俊洁, 王爽, 李伟强, 崔鑫, 黄超. 微波辅助无催化剂高效串联环化合成吡啶[2,3⁃d]嘧啶衍生物[J]. 高等学校化学学报, 2020, 41(12): 2749. |
[8] | 成沁雯, 袁波, 朱向东, 张凯, 张兴栋. 不同磺化及碱处理聚醚醚酮的表面化学组成及体外生物活性评价[J]. 高等学校化学学报, 2019, 40(8): 1757. |
[9] | 王琳, 张艳慧, 阿孜古丽·木尔赛力木, 兰海蝶. 以PS-b-P2VP为模板剂诱导调控聚苯胺形貌、尺寸及电化学性能[J]. 高等学校化学学报, 2019, 40(8): 1748. |
[10] | 刘书峰, 邱海燕, 姜涛, 张烨桦, 赵韵, 成汉文, 陈勇. 质子化非那吡啶在功能化复合介孔膜修饰的液/液界面上的转移反应[J]. 高等学校化学学报, 2019, 40(5): 973. |
[11] | 方芳,薛良敏,丛婧,田超,王孝伟,刘俊义,张志丽. 2-位或4-位取代吡啶并嘧啶类非经典叶酸拮抗剂的合成及抗肿瘤活性[J]. 高等学校化学学报, 2019, 40(10): 2111. |
[12] | 魏良晨, 胡伟康, 周世雄, 束俊, 周会东, 胡旭成, 姜毅, 童碧海, 张千峰. 含亚磷酸酯和联吡啶羧酸酯配体的铱配合物及其聚集诱导发光增强和电致发光性能[J]. 高等学校化学学报, 2018, 39(7): 1371. |
[13] | 赵邦屯, 陶晶晶, 陈小纪, 付慧敏, 朱卫民. 含噻吩和吡啶基的插烯式四硫富瓦烯衍生物的合成、 结构和电化学性质[J]. 高等学校化学学报, 2018, 39(7): 1449. |
[14] | 阮祥辉, 赵洪菊, 张橙, 陈丽娟, 李普, 王一会, 贺鸣, 薛伟. 含哌嗪酰胺类杨梅素衍生物的合成及生物活性[J]. 高等学校化学学报, 2018, 39(6): 1197. |
[15] | 苗瑞祥, 刘冬青, 任顺, 朱泽晛, 陈英波, 张宇峰. 聚(杯芳烃-哌嗪)酰胺与2,2'-联吡啶超分子泡沫网络结构的构筑[J]. 高等学校化学学报, 2018, 39(10): 2327. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||